[Docetaxel in the inductive therapy of head and neck cancer: recent evidence].
Benasso
Marco
M
Istituto Nazionale per la Ricerca sul Cancro, Genova.
Corvò
Renzo
R
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D000077143:Docetaxel; D019317:Evidence-Based Medicine; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D043823:Taxoids / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011838:Radiation-Sensitizing Agents; D043823:Taxoids; D000077143:Docetaxel